Connection

MICHAEL TAYLOR to Tumor Suppressor Proteins

This is a "connection" page, showing publications MICHAEL TAYLOR has written about Tumor Suppressor Proteins.
Connection Strength

0.155
  1. Tuberous sclerosis complex suppression in cerebellar development and medulloblastoma: separate regulation of mammalian target of rapamycin activity and p27 Kip1 localization. Cancer Res. 2009 Sep 15; 69(18):7224-34.
    View in: PubMed
    Score: 0.064
  2. New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs. Cell. 2016 Feb 25; 164(5):1060-1072.
    View in: PubMed
    Score: 0.025
  3. Pathological Findings of a Subependymal Giant Cell Astrocytoma Following Treatment With Rapamycin. Pediatr Neurol. 2015 Sep; 53(3):238-242.e1.
    View in: PubMed
    Score: 0.024
  4. Shh signaling protects Atoh1 from degradation mediated by the E3 ubiquitin ligase Huwe1 in neural precursors. Dev Cell. 2014 Jun 23; 29(6):649-61.
    View in: PubMed
    Score: 0.022
  5. DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies. Acta Neuropathol. 2013 Mar; 125(3):359-71.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.